Grace Therapeutics (GRCE) Stock Chart & Stock Price History $2.84 -0.05 (-1.73%) As of 01:55 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Grace Therapeutics Stock Price Performance The Grace Therapeutics (GRCE) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 24.06%. In the past month, the stock has decreased 4.05%, reflecting recent market activity. As of the latest close, Grace Therapeutics traded at $2.89 with a market cap of $39.97 million and volume of 23,901 shares. Receive GRCE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Grace Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-7.79%1 Month Performance-4.05%3 Month Performance+4.80%Year-To-Date Performance-24.06% GRCE Stock Chart for Friday, August, 1, 2025 GRCE Chart by TradingView Grace Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/31/2025$2.97$2.89-2.69%$3.06$2.8623,901 shs$39.97 million07/30/2025$2.98$2.97-0.34%$3.02$2.88116,803 shs$41.08 million07/29/2025$3.03$2.98-1.65%$3.06$2.9462,687 shs$41.21 million07/28/2025$3.08$3.03-1.62%$3.14$2.9871,996 shs$41.91 million07/25/2025$3.20$3.08-3.75%$3.19$3.0567,847 shs$42.60 million07/24/2025$3.35$3.20-4.48%$3.40$3.2042,850 shs$44.26 million07/23/2025$3.35$3.35$3.39$3.24155,993 shs$46.33 million07/22/2025$3.39$3.35-1.18%$3.45$3.3521,436 shs$46.33 million07/21/2025$3.36$3.39+0.89%$3.49$3.3058,294 shs$46.88 million07/18/2025$3.35$3.36+0.30%$3.40$3.2436,929 shs$46.47 million Get the Latest News and Ratings for GRCE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Grace Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/17/2025$3.34$3.35+0.30%$3.45$3.2830,659 shs$46.33 million07/16/2025$3.19$3.34+4.70%$3.35$3.1060,258 shs$46.19 million07/15/2025$3.31$3.19-3.63%$3.41$3.1552,402 shs$44.12 million07/14/2025$3.44$3.31-3.78%$3.74$3.29127,399 shs$45.78 million07/11/2025$3.10$3.44+10.97%$3.50$3.07155,956 shs$47.58 million07/10/2025$3.07$3.10+0.98%$3.15$3.0532,877 shs$42.87 million07/09/2025$3.04$3.07+0.99%$3.15$2.99107,228 shs$42.46 million07/08/2025$3.00$3.04+1.33%$3.07$3.00111,749 shs$42.04 million07/07/2025$3.13$3.00-4.15%$3.10$2.9742,106 shs$41.49 million07/04/2025$3.13$3.13$3.17$3.0128,627 shs$43.29 million07/03/2025$3.02$3.13+3.64%$3.17$3.0128,627 shs$43.29 million07/02/2025$2.96$3.02+2.03%$3.03$2.9850,362 shs$41.76 million07/01/2025$2.97$2.96-0.34%$3.00$2.9416,034 shs$40.94 million06/30/2025$2.97$2.97$3.00$2.9119,137 shs$41.08 million Related Companies Lifevantage Stock Price Chart I-Mab Stock Price Chart Puma Biotechnology Stock Price Chart BioAge Labs Stock Price Chart C4 Therapeutics Stock Price Chart Nuvectis Pharma Stock Price Chart Alpha Cognition Stock Price Chart Molecular Partners Stock Price Chart Enanta Pharmaceuticals Stock Price Chart Lyell Immunopharma Stock Price Chart Receive GRCE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Grace Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GRCE) was last updated on 8/1/2025 by MarketBeat.com Staff From Our PartnersCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredIf you saw this, you'd be scared tooMarkets may look strong—but one veteran analyst warns we’re nearing a financial breaking point. After 40+ y...InvestorPlace | SponsoredWhy “The Prophet” Is Betting Big on This $10 StockAmerica's Biggest Land Grab Is Not Where You Think While the media focuses on coastal cities and farmland.....Stansberry Research | SponsoredMusk's Big Prediction for 2025Elon Musk just made a bold prediction about 2025—and it could upend the entire tech sector. If he’s right, ...The Oxford Club | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Grace Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Grace Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GRCE Stock Alerts